Samsung Medical Center (삼성서울병원; SMC) is a tertiary referral hospital in Gangnam District, Seoul, South Korea, operated by the Samsung Life Public Welfare Foundation.[1][2] It opened on 9 November 1994 and has served as a teaching hospital of Sungkyunkwan University School of Medicine since 1997.[1][3] As of 31 December 2024, the hospital operated 1,766 beds and employed 7,929 staff, including 915 physicians and 3,337 nurses.[1] Its major clinical institutes include the Samsung Comprehensive Cancer Center, opened in 2008, and the Heart Vascular Stroke Institute, established in 2014.[1]
The hospital conducts biomedical research through the Research Institute for Future Medicine and has received Stage 7 validation, the highest level, under all four maturity models administered by the Healthcare Information and Management Systems Society (HIMSS).[4][5][6] In 2015, the hospital suffered an outbreak of Middle East respiratory syndrome,[7] and was criticised for its poor handling of the incident.[8]
References
- 1 2 3 4 Samsung Medical Center. 2024 Annual Report (PDF) (Report). pp. 9–41. Retrieved 2026-08-04.
- ↑ "Samsung Medical Center". Korea Tourism Organization. Retrieved 2026-08-04.
- ↑ "Organizational Chart". Sungkyunkwan University. Retrieved 2026-08-04.
- ↑ "Samsung Medical Center achieves Stage 7 DIAM and EMRAM". Healthcare IT News. Retrieved 2026-08-04.
- ↑ "HIMSS Validates First Stage 7 INFRAM Worldwide for Samsung Medical Center in South Korea". HIMSS. Retrieved 2026-08-04.
- ↑ "Samsung Medical Center Earns 2024 Davies Award, First-Ever in the Republic of Korea". HIMSS. Retrieved 2026-08-04.
- ↑ "South Korea hospital 'is source of many Mers cases'". BBC News. 2015-06-14. Retrieved 2021-07-17.
- ↑ "Samsung stigmatized with MERS". The Korea Times. 2015-06-14. Retrieved 2021-07-17.
